Pilnik Richard D. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Pilnik Richard D.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-01+22,355→ 22,355 totalExercise: $2.73Exp: 2033-05-31→ Common Shares (22,355 underlying)
Holdings
- 209,882
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 99,204 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
- [F2]Vests in four nearly equal quarterly installments over one year.